Award
Omphalos Secures BARDA Support for Pathogen-Agnostic Antimicrobial Strategy Simulation
We are excited to share that Omphalos Lifesciences Inc has been selected to receive non-dilutive support from Biomedical Advanced Research and Development Authority (BARDA) through MATTER’s Paratus digital health program! 👉 Read the full article on MATTER’s website This support enables us to advance our 𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐚𝐛𝐥𝐞 𝐯𝐢𝐫𝐭𝐮𝐚𝐥 𝐜𝐞𝐥𝐥 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 by Read more…
